ReviewFrontiers in oncology2021

Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women.

Yen-Shen Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.